MELYNDA BUELL: Open Payments
NPI 1578848040 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$109 in 6 payments from 5 companies in 2025. Trend: 2023 $154 · 2024 $65 · 2025 $109
Food & beverage: $109
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $37 |
| Astellas Pharma US Inc | 1 | $24 |
| Boston Scientific Corporation | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: Veozah, Ozempic, WATCHMAN FLX, CAPVAXIVE, Wegovy, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
